Sentences with phrase «potential liability exposure»

It could also be saying that you don't have kids when you do, as they're a potential liability exposure.
Whether serving as lead trial counsel, working collaboratively with other law firms as part of a nationwide «virtual law firm,» coordinating document review and management, serving as national settlement processing counsel, or counseling clients on ways to limit potential liability exposure, members of Bryan Cave's Product Liability team have demonstrated a superior ability to work with clients to meet their legal needs.
Our lawyers also advise on potential liability exposure and help evaluate the adequacy of insurance before coverage issues arise.
The Firm also advises clients regarding certain risks and will develop a support program to reduce potential liability exposure.
Provided legal advice to a national telematics service provider regarding potential liability exposure arising out of contracts to provide emergency medical services, including emergency medical dispatch and pre-arrival instructions, through satellite and cellular technology installed in automobiles.
Mold that appears to be a considerable health hazard — this increases AmeriFirst's potential liability exposure and can put the borrower (s) and their family at risk health wise.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Finance and insurance companies would need to verify their total liabilities, to both each other and what their potential exposure to US debt would be.
In the event of unexpected results leading to potential liability, our firm's health care attorneys work with clients to formulate a strategy to minimize their exposure.
Drawing on the experience of both the plaintiff and defence side of our firm, our lawyers can expertly evaluate the potential liability and quantum of our client's exposure.
A successful product liability defense requires a law firm that has the experience and resources necessary to protect against serious allegations and potential exposure.
The result of the case also creates greater potential exposure to directors and officers of corporations that have environmental liabilities.
The doctrine is based on a fear that exposure to potential damages liability might impair the impartiality and independence of the judiciary.
Mr. Fousekis counsels and advises clients on case strategy, liability issues, and mitigating potential exposure in labor and employment matters including claims for wrongful termination, harassment, and discrimination claims under the Fair Employment and Housing Act.
We assist clients in developing and implementing FCPA / anti-corruption compliance programs; provide advice regarding specific transactions and activities, enabling clients to minimize exposure under the anti-corruption statutes; and assist with due diligence for potential acquisitions and business transactions, enabling clients to avoid acquiring an FCPA or U.K. Bribery Act liability.
Perhaps nowhere is this problem more acute than in cross-border litigation where these companies must comply with the Federal Rules of Civil Procedure (FRCP) during discovery in spite of potential exposure to civil and criminal liability in foreign jurisdictions.
The health care industry continues to hold great potential for private equity (PE) firms, but it also carries with it significant risks and potential exposure to liability.
Can lawyers have liability exposure to potential clients that they do not end up acting for?
Orrick's ERISA and Benefits Litigation lawyers counsel clients on withdrawal liability exposure in multiemployer pension plans and on the effects of asset sales and corporate transactions on potential withdrawal liability.
That's why it is so important to weigh the potential exposure to your personal net worth when you are deciding how much liability coverage to buy.
Protect against and prevent fraud, unauthorized transactions, claims and other liabilities, and manage risk exposure, including by identifying potential hackers and other unauthorized users.
Be sure to record statistics throughout the workforce reduction planning process to identify potential legal liability exposure as discussed earlier in Reduced Legal Exposure and Lliability exposure as discussed earlier in Reduced Legal Exposure and Liexposure as discussed earlier in Reduced Legal Exposure and LiExposure and LiabilityLiability.
a b c d e f g h i j k l m n o p q r s t u v w x y z